Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

TOVX — Theriva Biologics, Inc. SEC Filings | FilingIndex

TOVXNYSE

Theriva Biologics, Inc.

Pharmaceutical Preparations · NV · CIK 894158

Developing oncolytic adenovirus therapeutics to treat cancer and related diseases

+ Watch View on EDGAR ↗

$14M

Market cap

$0.25

Last close

-3.8%

1D

-1.1%

5D

513K

Volume

Price · last 40 sessions-34.1%

May 4L $0.24 · H $0.38Jun 30

572

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

All 8-K · 348 10-Q · 71 DEF 14A · 31 424B5 · 29 10-K · 23 SC 13G · 20 DEFA14A · 14 8-K/A · 11

8-K/ACompany UpdateSep 6, 2022 8-K/AAcquisition / DispositionMay 6, 2022 8-K/AEquity IssuanceFeb 12, 2021 8-K/ABylaw Amendment · Shareholder VoteFeb 1, 2021 8-K/ARestatementMay 30, 2012 8-K/A

Similar companies

Comparable business profile · signals at a glance

GNLXGENELUX Corp$132.7M+3.8%WHWKWhitehawk Therapeutics, Inc.$205.7M+3.9%STROSUTRO BIOPHARMA, INC.$477.2M-0.5%PGENPRECIGEN, INC.$1.6B-3.7%VSTMVerastem, Inc.

Company Update

Feb 3, 2012

8-K/AExecutive ChangeMar 31, 2010

8-K/AMaterial Agreement · Acquisition / DispositionOct 19, 2009

8-K/AAcquisition / DispositionSep 24, 2009

8-K/AAuditor Change · Change of ControlNov 7, 2006

8-K/ACompany UpdateDec 21, 2001

$360.3M

0.0%

CADLCandel Therapeutics, Inc.$627.2M-0.6%